Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

EpiSeedLink From seed to seedling: Epigenetic mechanisms of priming to design strategies for crop improvement

Coordinator
Agencia Estatal Consejo Superior De Investigaciones Cientificas, Spain
Runs
1 October 2022 to 30 September 2026
Status
Running
EU funding
€2.7m
Total cost
—
Partners
24 organisations in 7 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101073476

What the project is doing

In the project's own words, from its summary on CORDIS.

The overreaching mission of EpiSeedLink is to foster a European network that empowers crop improvement through epigenetics by providing expertise, know-how, and creativity in high-end technologies to 11 early stage scientists and enabling them to translate scientific knowledge and skills into innovation. Through international, multidisciplinary, and inter-sectorial training in experimental and computational biology, EpiSeedLink will contribute to excellence in research and also timely address societal and agricultural needs.

This original research program combines the unique know-how of academic experts with that of two companies to synergize research and knowledge transfer between a plant model and a crop of enormous agroeconomic importance (oilseed rape). EpiSeedLink will exploit the epigenetic regulation of seed priming mechanisms to improve crop performance under threats caused by climate change (i.e drought) through non-GMO practices.

Crop breeding strategies have led to genetic erosion. A critical challenge is to identify new genetic and epigenetic markers for crop selection programs and for bioengineering the intrinsic performance of seeds or their enhancement through farming practices referred to as 'seed priming' strategies. These include chemical osmopriming and biostimulants use, that enhance germination efficiency and drought tolerance. Despite being a broadly adopted agriculture technique, the molecular determinants of seed priming are just starting to emerge and the nature, duration and implementation of plant priming remain poorly understood.

These gaps in mechanistic understanding have so far precluded fully exploiting the biotechnological potential of seed priming. EpiSeedLink aims to fill these gaps by 1) understanding which chromatin regulatory layers contribute to improve plant performance to environmental threats through priming and by 2) exploiting epigenome diversity to provide markers of crop traits and strategies to the seed industry.

Topics

Who is involved

OrganisationCityCountryRole
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainCoordinator
Universitat ZurichZurichSwitzerlandAssociatedpartner
2bind GmbHRegensburgGermanyAssociatedpartner
Deutsche Saatveredelung AGLippstadtGermanyParticipant
Georg-August-Universitat Gottingen Stiftung Offentlichen RechtsGottingenGermanyAssociatedpartner
Heinrich-Heine-Universitaet DuesseldorfDusseldorfGermanyAssociatedpartner
Science CraftBerlinGermanyAssociatedpartner
Universitaet RegensburgRegensburgGermanyParticipant
Pons Ip SAMadridSpainAssociatedpartner
Sequentia Biotech SLBarcelonaSpainAssociatedpartner
Universidad Autonoma De MadridMadridSpainAssociatedpartner
Universidad Politecnica De MadridMadridSpainAssociatedpartner
Universitat Politecnica De ValenciaValenciaSpainAssociatedpartner
Centre National De La Recherche Scientifique CNRSParisFranceAssociatedpartner
Ecole Normale SuperieureParisFranceParticipant
Universite Clermont AuvergneClermont-FerrandFranceParticipant
Universite Paris-SaclayGif-Sur-YvetteFranceAssociatedpartner
Bioatlantis LimitedTralee KerryIrelandParticipant
University College Dublin, National University of Ireland, DublinDublinIrelandAssociatedpartner
University of GalwayGalwayIrelandParticipant
Moile MoileHaarlemNetherlandsAssociatedpartner
Universiteit Van AmsterdamAmsterdamNetherlandsParticipant
Careers Research and Advisory Centre (crac) Limited (the)CambridgeUnited KingdomAssociatedpartner
Nuspec Bioscience LimitedYorkUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI